Beam Therapeutics Inc.BEAMNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-21.41%
↑ 100% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
-133307.83%
Historical baseline
PeriodValueYoY Change
2025-21.41%+96.5%
2024-619.73%-1492.9%
2023-38.91%+92.7%
2022-532.39%-20.0%
2021-443.76%+99.9%
2020-533437.50%-34.0%
2019-398061.11%-